Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-09

Clinical Trial Update: Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria [Phase 4]

View source ↗

Summary

A Phase 4 trial completed comparing Riamet (artesunate-mefloquine) with Malarone (atovaquone-proguanil) for treating uncomplicated malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)
  • Riamet (artemether-lumefantrine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Malaria | Phase 4 | Status: COMPLETED